There is increased risk of depression, anxiety, or SI in patients with uveitis or scleritis, including those with ocular complications or those prescribed systemic corticosteroids. These data highlight the need for physicians to consider a psychiatric review of systems into clinic visits for treatment of ocular inflammatory conditions.
Agarwal et al. (Fri,) studied this question.